Here's hoping the pink wave washes the label of “women's issues” off the legislative agenda.
After nearly two decades of concerted efforts, it's time for the National Academies to judge whether quality and safety have improved and where new work is needed most.
For decades, demographers and economists have predicted the gray tsunami of aging baby boomers would inevitably push healthcare spending over 20% of GDP. But a new paper highlights some recent trends suggesting the future may not be as bleak and hard to manage as predicted.
Tariff battles, whether in 1992 or 2018, will not solve what remains one of U.S. businesses' main international competitiveness problems: the higher prices they pay for healthcare and the tab's uneven distribution.
The share of Americans without health coverage will undoubtedly tick up next year for the first time in nearly a decade. This dubious achievement arrives just as the U.S. economy is nearing full employment. This shouldn't be happening.
Physicians who tend to the nation's gunshot victims pushed back against an NRA tweet telling them to "stay in their lane" after the American College of Physicians updated its positions on reducing gun injuries and deaths.
Repeal-and-replace is dead, buried, gone. Medicaid expansion passed everywhere it was on the ballot. The Affordable Care Act, with its core premise that health insurance is the right of every citizen, lives.
Once the heat of the campaign dissipates, a majority in both parties will remain susceptible to their main argument that high prices are necessary to promote innovation.
The caravan of Central American migrants making its way north may well determine the future of healthcare in America.
The healthcare industry, which has embraced a sea change in recent years at the behest of consumers, should now embrace the idea that price transparency is here to stay.
Grassroots activism is behind both good and bad trends in policy. Consumer coalitions are behind Medicaid expansion ballot measures in several states, while other coalitions are pinpointing dialysis policy and staffing ratios.
The prospect of another huge healthcare merger—this time involving two of Texas' more prestigious hospital systems—is the surest signal yet that even the industry's strongest players are having a difficult time navigating the rapidly shifting healthcare landscape.